Paul V. Maier - Jun 14, 2023 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Director
Signature
/s/ Russell Kern, Attorney-in-Fact
Stock symbol
ISCO
Transactions as of
Jun 14, 2023
Transactions value $
$0
Form type
4
Date filed
6/16/2023, 05:23 PM
Previous filing
Jun 9, 2023
Next filing
Feb 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jun 14, 2023 Common Stock 30K $0.14 Direct F1
transaction ISCO Stock Option (Right to Buy) Award $0 +445K $0.00 445K Jun 14, 2023 Common Stock 445K $0.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest fully at the earlier of (i) 06/14/2024 or (ii) the date of the 2024 Annual Meeting of Stockholders.
F2 Options vest in four equal quarterly increments, beginning 09/14/2023.